Covered recipient · General Payments record
SABRINA SASSOUI-DOLAN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2022
$177.51
- Reported across 7 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2022 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $177.51 | 7 |
By paying entity
PY2022 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ARGENX US, INC. | $46.34 | 1 |
| Teva Pharmaceuticals USA, Inc. | $36.63 | 2 |
| GENZYME CORPORATION | $33.12 | 1 |
| Amgen Inc. | $25.10 | 1 |
| Lilly USA, LLC | $20.45 | 1 |
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | $15.87 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2022 | $177.51 | 7 |
Payment records · PY2022 (7)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $25.10 | 10/12/2022 | Food and Beverage | Undisputed | 01/23/2026 | 939777643 | CMS |
| ARGENX US, INC. | $46.34 | 10/05/2022 | Food and Beverage | Undisputed | 01/23/2026 | 951641541 | CMS |
| Biohaven Pharmaceutical Holding Company Ltd. | $15.87 | 05/03/2022 | Food and Beverage | Undisputed | 01/23/2026 | 923935983 | CMS |
| GENZYME CORPORATION | $33.12 | 08/17/2022 | Food and Beverage | Undisputed | 01/23/2026 | 938893183 | CMS |
| Lilly USA, LLC | $20.45 | 09/21/2022 | Food and Beverage | Undisputed | 01/23/2026 | 918672029 | CMS |
| Teva Pharmaceuticals USA, Inc. | $15.45 | 04/27/2022 | Food and Beverage | Undisputed | 01/23/2026 | 954833693 | CMS |
| Teva Pharmaceuticals USA, Inc. | $21.18 | 11/09/2022 | Food and Beverage | Undisputed | 01/23/2026 | 954833481 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022
- Source files
- Dataset page · Bulk file · PY2022
- Generated from
- OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.